Filamon was awarded an exclusive license for a groundbreaking experimental anti-cancer drug developed by Australian university scientists. Australian clinical-stage drug development company, Filamon Limited, announced
A new Australian bio-technology company secures a licence to develop a drug to block the development of metastatic prostate cancer. Filamon Limited, an Australian drug
Healthcare Channel – Sharing knowledge and resources for Australia’s health and aged care sector
We always welcome thought leaders ready to mentor the next generation. Be a Healthcare Channel learning partner today!
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.
